NCT06171204 The Use of Stromal Vascular Fraction for Knee Arthrosis
| NCT ID | NCT06171204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Knee Arthrosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2022-09-19 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2022-09-19 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.
Eligibility Criteria
Inclusion Criteria: * Legal capacity * Osteochondral lesions * Inflammatory complaints * (Peri)tendinitis or tendinopathies and ligamentous injuries * Impingement complaints * Arthrofibrosis * Anterior knee pain
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06171204 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Knee Arthrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06171204 currently recruiting?
Yes, NCT06171204 is actively recruiting participants. Contact the research team at bernard.depypere@ugent.be for enrollment information.
Where is the NCT06171204 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT06171204 clinical trial?
NCT06171204 is sponsored by University Hospital, Ghent. The trial plans to enroll 10 participants.